Screening for Lung Cancer: For Patients at Increased Risk for Lung Cancer, It Works
Authors:
- 18 October 2011
- journal article
- case report
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 155 (8) , 540-542
Abstract
Screening for lung cancer is not currently recommended, even in persons at high risk for this condition. Most patients with lung cancer present with symptomatic disease that is usually at an incurable, advanced stage. The recently reported NLST (National Lung Screening Trial) showed a 20% decrease in deaths from lung cancer in high-risk persons undergoing screening with low-dose computed tomography of the chest compared with chest radiography. The high-risk group included in the trial comprised asymptomatic persons aged 55 to 74 years, with smoking history of at least 30 pack-years. Screening with low-dose computed tomography detected more cases of early-stage lung cancer and fewer cases of advanced-stage cancer, confirming that screening has shifted the stage of cancer at diagnosis and provides more persons with the opportunity for curative treatment. Although computed tomography screening has risks and limitations, the 20% decrease in deaths is the single most dramatic decrease ever reported for deaths from lung cancer, with the possible exception of smoking cessation. Physicians should offer computed tomography screening for lung cancer to patients who fit the high-risk profile defined in the NLST.Keywords
This publication has 31 references indexed in Scilit:
- Projected Cancer Risks From Computed Tomographic Scans Performed in the United States in 2007Archives of internal medicine (1960), 2009
- Management of Lung Nodules Detected by Volume CT ScanningNew England Journal of Medicine, 2009
- Common 5p15.33 and 6p21.33 variants influence lung cancer riskNature Genetics, 2008
- Lung cancer susceptibility locus at 5p15.33Nature Genetics, 2008
- A variant associated with nicotine dependence, lung cancer and peripheral arterial diseaseNature, 2008
- Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1Nature Genetics, 2008
- A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25Nature, 2008
- The LLP risk model: an individual risk prediction model for lung cancerBritish Journal of Cancer, 2007
- Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screeningCancer, 2005
- Change in smoking status after spiral chest computed tomography scan screeningCancer, 2003